These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

399 related items for PubMed ID: 2370223

  • 1. Plasma cortisol response to ketoconazole administration in dogs with hyperadrenocorticism.
    Feldman EC, Bruyette DS, Nelson RW, Farver TB.
    J Am Vet Med Assoc; 1990 Jul 01; 197(1):71-8. PubMed ID: 2370223
    [Abstract] [Full Text] [Related]

  • 2. Comparison of two low-dose dexamethasone suppression protocols as screening and discrimination tests in dogs with hyperadrenocorticism.
    Mack RE, Feldman EC.
    J Am Vet Med Assoc; 1990 Dec 15; 197(12):1603-6. PubMed ID: 2177458
    [Abstract] [Full Text] [Related]

  • 3. Comparison of mitotane treatment for adrenal tumor versus pituitary-dependent hyperadrenocorticism in dogs.
    Feldman EC, Nelson RW, Feldman MS, Farver TB.
    J Am Vet Med Assoc; 1992 Jun 01; 200(11):1642-7. PubMed ID: 1320600
    [Abstract] [Full Text] [Related]

  • 4. Hyperadrenocorticism caused by bilateral adrenocortical neoplasia in dogs: four cases (1983-1988).
    Ford SL, Feldman EC, Nelson RW.
    J Am Vet Med Assoc; 1993 Mar 01; 202(5):789-92. PubMed ID: 8454518
    [Abstract] [Full Text] [Related]

  • 5. Plasma cortisol response to exogenous ACTH in 22 dogs with hyperadrenocorticism caused by adrenocortical neoplasia.
    Peterson ME, Gilbertson SR, Drucker WD.
    J Am Vet Med Assoc; 1982 Mar 01; 180(5):542-4. PubMed ID: 6277837
    [Abstract] [Full Text] [Related]

  • 6. Use of ketoconazole to treat dogs with pituitary-dependent hyperadrenocorticism: 48 cases (1994-2007).
    Lien YH, Huang HP.
    J Am Vet Med Assoc; 2008 Dec 15; 233(12):1896-901. PubMed ID: 19072605
    [Abstract] [Full Text] [Related]

  • 7. Use of low- and high-dose dexamethasone tests for distinguishing pituitary-dependent from adrenal tumor hyperadrenocorticism in dogs.
    Feldman EC, Nelson RW, Feldman MS.
    J Am Vet Med Assoc; 1996 Aug 15; 209(4):772-5. PubMed ID: 8756877
    [Abstract] [Full Text] [Related]

  • 8. Use of the urine cortisol-to-creatinine ratio for monitoring dogs with pituitary-dependent hyperadrenocorticism during induction treatment with mitotane (o,p'-DDD).
    Randolph JF, Toomey J, Center SA, Scarlett JM, Reimers T, Graham P, Nachreiner RF.
    Am J Vet Res; 1998 Mar 15; 59(3):258-61. PubMed ID: 9522940
    [Abstract] [Full Text] [Related]

  • 9. Evaluation of a low-dose synthetic adrenocorticotropic hormone stimulation test in clinically normal dogs and dogs with naturally developing hyperadrenocorticism.
    Kerl ME, Peterson ME, Wallace MS, Melián C, Kemppainen RJ.
    J Am Vet Med Assoc; 1999 May 15; 214(10):1497-501. PubMed ID: 10340075
    [Abstract] [Full Text] [Related]

  • 10. Results of surgical treatment for hyperadrenocorticism caused by adrenocortical neoplasia in the dog: 25 cases (1980-1984).
    Scavelli TD, Peterson ME, Matthiesen DT.
    J Am Vet Med Assoc; 1986 Nov 15; 189(10):1360-4. PubMed ID: 3793588
    [Abstract] [Full Text] [Related]

  • 11. Non-dexamethasone-suppressible, pituitary-dependent hyperadrenocorticism in a dog.
    Kemppainen RJ, Zenoble RD.
    J Am Vet Med Assoc; 1985 Aug 01; 187(3):276-8. PubMed ID: 4030467
    [Abstract] [Full Text] [Related]

  • 12. Mitotane treatment of 32 dogs with cortisol-secreting adrenocortical neoplasms.
    Kintzer PP, Peterson ME.
    J Am Vet Med Assoc; 1994 Jul 01; 205(1):54-61. PubMed ID: 7928549
    [Abstract] [Full Text] [Related]

  • 13. Effects of disease on the results of diagnostic tests for use in detecting hyperadrenocorticism in dogs.
    Kaplan AJ, Peterson ME, Kemppainen RJ.
    J Am Vet Med Assoc; 1995 Aug 15; 207(4):445-51. PubMed ID: 7591942
    [Abstract] [Full Text] [Related]

  • 14. Lipid metabolism in horses with hyperadrenocorticism.
    van der Kolk JH, Wensing T, Kalsbeek HC, Breukink HJ.
    J Am Vet Med Assoc; 1995 Apr 01; 206(7):1010-2. PubMed ID: 7768707
    [Abstract] [Full Text] [Related]

  • 15. Problems associated with medical therapy of canine hyperadrenocorticism.
    Nichols R.
    Probl Vet Med; 1990 Dec 01; 2(4):551-6. PubMed ID: 2134073
    [Abstract] [Full Text] [Related]

  • 16. Evaluation of the use of baseline cortisol concentration as a monitoring tool for dogs receiving trilostane as a treatment for hyperadrenocorticism.
    Cook AK, Bond KG.
    J Am Vet Med Assoc; 2010 Oct 01; 237(7):801-5. PubMed ID: 20919845
    [Abstract] [Full Text] [Related]

  • 17. Effect of functional adrenocortical tumors on plasma cortisol and corticotropin concentrations in dogs.
    Feldman EC.
    J Am Vet Med Assoc; 1981 Apr 15; 178(8):823-6. PubMed ID: 6268586
    [Abstract] [Full Text] [Related]

  • 18. Diagnosis of hyperadrenocorticism in dogs as compared to human diagnostic methods: a review.
    Thuróczy J, Balogh L, Huszenicza G, Jánoki GA, Kulcsár M.
    Acta Vet Hung; 1998 Apr 15; 46(2):157-73. PubMed ID: 9704520
    [Abstract] [Full Text] [Related]

  • 19. Plasma free cortisol concentrations in dogs with hyperadrenocorticism.
    Kemppainen RJ, Peterson ME, Sartin JL.
    Am J Vet Res; 1991 May 15; 52(5):682-6. PubMed ID: 1649561
    [Abstract] [Full Text] [Related]

  • 20. ACTH-independent hyperadrenocorticism due to food-dependent hypercortisolemia in a dog: a case report.
    Galac S, Kars VJ, Voorhout G, Mol JA, Kooistra HS.
    Vet J; 2008 Jul 15; 177(1):141-3. PubMed ID: 17572120
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.